title: Cerebrovascular events during nilotinib treatment.
authors.affiliation: Department of Clinical Pharmacology, Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
authors.forename: N G L
authors.initials: NG
authors.lastname: Jager
authors.forename: F E
authors.initials: FE
authors.lastname: Stuurman
authors.forename: J W
authors.initials: JW
authors.lastname: Baars
authors.forename: F L
authors.initials: FL
authors.lastname: Opdam
mesh_terms: D000368:Aged; D002545:Brain Ischemia / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D011743:Pyrimidines; D011505:Protein-Tyrosine Kinases; C498826:nilotinib